Skip to main content
Top
Published in: Hepatology International 4/2009

Open Access 01-12-2009 | Original Article

Liver transplantation for acute-on-chronic liver failure

Authors: Albert C. Chan, Sheung Tat Fan, Chung Mau Lo, Chi Leung Liu, See Ching Chan, Kelvin K. Ng, Boon Hun Yong, Alexander Chiu, Banny K. Lam

Published in: Hepatology International | Issue 4/2009

Login to get access

Abstract

Purpose

To evaluate the outcome of liver transplantation for acute-on-chronic liver failure.

Patients and methods

From November 1991 to December 2007, 517 patients underwent liver transplantation at Queen Mary Hospital, Hong Kong. Among them, 149 had acute-on-chronic liver failure as defined in the recent Asian Pacific Association for the Study of Liver Consensus Meeting. Their clinical data were reviewed and their survival outcomes were compared with those of patients who underwent liver transplantation for fulminant hepatic failure and for cirrhosis only in the same period.

Results

The patients with acute-on-chronic liver failure included 50 patients having acute exacerbation of chronic hepatitis B and 99 cirrhotic patients with acute deterioration. Their median model for end-stage liver disease scores were 35 and 37, respectively. Preoperative infection (35%), hepatorenal syndrome (38%), and respiratory failure (28.8%) were common. One hundred and three patients received living donor liver grafts and 46 patients received deceased donor liver grafts. The hospital mortality rate was 4.7%. The 5-year survival rates were 93.2% for patients with acute exacerbation of chronic hepatitis B and 90.5% for cirrhotic patients with acute deterioration. The results were similar to those of the patients with fulminant hepatic failure (n = 37) and the patients having cirrhosis only (n = 301).

Conclusions

Liver transplantation for acute-on-chronic liver failure is life-saving, and the survival rates it attains are similar to those attained by transplantation for other liver conditions.
Literature
1.
go back to reference Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the liver (APASL). Hepatol Int 2009;3:269–282CrossRefPubMed Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the liver (APASL). Hepatol Int 2009;3:269–282CrossRefPubMed
2.
go back to reference Conn H, Bircha J. The Hepatic Encephalopathies. In Conn HB, Bircha J, editors. Hepatic Encephalopathy. Syndromes and Therapies. Bloomington, IL: Medi-Ed Press; 1994. 1–12 Conn H, Bircha J. The Hepatic Encephalopathies. In Conn HB, Bircha J, editors. Hepatic Encephalopathy. Syndromes and Therapies. Bloomington, IL: Medi-Ed Press; 1994. 1–12
3.
go back to reference O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439–445PubMed O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439–445PubMed
4.
go back to reference Chiu A, Chan LM, Fan ST. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience. Liver Int 2006;26:695–702CrossRefPubMed Chiu A, Chan LM, Fan ST. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience. Liver Int 2006;26:695–702CrossRefPubMed
5.
go back to reference Chan SC, Fan ST, Liu CL, Lo CM, Lam BK, Lee EW. Working up donors for high-urgency and elective adult-to-adult live donor liver transplantation. Liver Transpl 2007;13:509–515CrossRefPubMed Chan SC, Fan ST, Liu CL, Lo CM, Lam BK, Lee EW. Working up donors for high-urgency and elective adult-to-adult live donor liver transplantation. Liver Transpl 2007;13:509–515CrossRefPubMed
7.
go back to reference Fan ST, Yong BH, Lo CM, Liu CL, Wong J. Right lobe living donor liver transplantation with or without venovenous bypass. Br J Surg 2003;90:48–56CrossRefPubMed Fan ST, Yong BH, Lo CM, Liu CL, Wong J. Right lobe living donor liver transplantation with or without venovenous bypass. Br J Surg 2003;90:48–56CrossRefPubMed
8.
go back to reference Liu CL, Fan ST, Lo CM, Chan SC, Ng IO, Lai CL, et al. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liver Transpl 2004;10:728–733CrossRefPubMed Liu CL, Fan ST, Lo CM, Chan SC, Ng IO, Lai CL, et al. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liver Transpl 2004;10:728–733CrossRefPubMed
9.
go back to reference Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996;23:164–176CrossRefPubMed Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996;23:164–176CrossRefPubMed
10.
go back to reference Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–470CrossRefPubMed Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–470CrossRefPubMed
11.
go back to reference Goldstein MJ, Salame E, Kapur S, Kinkhabwala M, LaPointe-Rudow D, Harren NPP, et al. Analysis of failure in living donor liver transplantation: differential outcomes in children and adults. World J Surg 2003;27:356–364CrossRefPubMed Goldstein MJ, Salame E, Kapur S, Kinkhabwala M, LaPointe-Rudow D, Harren NPP, et al. Analysis of failure in living donor liver transplantation: differential outcomes in children and adults. World J Surg 2003;27:356–364CrossRefPubMed
12.
go back to reference Marcos A, Ham JM, Fisher RA, Olzinski AT, Posner MP. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 2000;6:296–301CrossRefPubMed Marcos A, Ham JM, Fisher RA, Olzinski AT, Posner MP. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 2000;6:296–301CrossRefPubMed
13.
go back to reference Icoz G, Kilic M, Zeytunlu M, Celebi A, Ersoz G, Killi R, et al. Biliary reconstructions and complications encountered in 50 consecutive right-lobe living donor liver transplantations. Liver Transpl 2003;9:575–580CrossRefPubMed Icoz G, Kilic M, Zeytunlu M, Celebi A, Ersoz G, Killi R, et al. Biliary reconstructions and complications encountered in 50 consecutive right-lobe living donor liver transplantations. Liver Transpl 2003;9:575–580CrossRefPubMed
14.
go back to reference Rajekar H, Wai CT, Majeed TA, Lee KH, Wong SY, Leong SO, et al. Prognostic factors in patients with acute liver failure undergoing live donor liver transplantation. Transplant Proc 2008;40(8):2492–2493CrossRefPubMed Rajekar H, Wai CT, Majeed TA, Lee KH, Wong SY, Leong SO, et al. Prognostic factors in patients with acute liver failure undergoing live donor liver transplantation. Transplant Proc 2008;40(8):2492–2493CrossRefPubMed
15.
go back to reference Fan ST, Lo CM, Liu CL, Wang WX, Wong J. Safety and necessity of including the middle hepatic vein in the right lobe graft in adult-to-adult live donor liver transplantation. Ann Surg 2003;238:137–148CrossRefPubMed Fan ST, Lo CM, Liu CL, Wang WX, Wong J. Safety and necessity of including the middle hepatic vein in the right lobe graft in adult-to-adult live donor liver transplantation. Ann Surg 2003;238:137–148CrossRefPubMed
16.
go back to reference Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002;36:949–958PubMed Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002;36:949–958PubMed
17.
go back to reference Yuen MF, Sablon E, Hui CK, Li TM, Yuan HJ, Wong DK, et al. Prognostic factors in severe exacerbation of chronic hepatitis B. Clin Infect Dis 2003;36:979–984CrossRefPubMed Yuen MF, Sablon E, Hui CK, Li TM, Yuan HJ, Wong DK, et al. Prognostic factors in severe exacerbation of chronic hepatitis B. Clin Infect Dis 2003;36:979–984CrossRefPubMed
Metadata
Title
Liver transplantation for acute-on-chronic liver failure
Authors
Albert C. Chan
Sheung Tat Fan
Chung Mau Lo
Chi Leung Liu
See Ching Chan
Kelvin K. Ng
Boon Hun Yong
Alexander Chiu
Banny K. Lam
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
Hepatology International / Issue 4/2009
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-009-9148-8

Other articles of this Issue 4/2009

Hepatology International 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.